Vident Advisory, LLC Corcept Therapeutics Inc Transaction History
Vident Advisory, LLC
- $3.97 Trillion
- Q3 2024
A detailed history of Vident Advisory, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 115,892 shares of CORT stock, worth $6.22 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
115,892
Previous 186,020
37.7%
Holding current value
$6.22 Million
Previous $6.04 Billion
11.26%
% of portfolio
0.13%
Previous 0.17%
Shares
6 transactions
Others Institutions Holding CORT
# of Institutions
346Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$887 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$537 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$443 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$349 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$205 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.74B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...